The amount of work that goes into the development of a dosage form is typically determined by the molecule’s physio-chemical needs, the phase of development, and a company’s corporate goals and objectives. In the earliest phase, it may not be wise to invest a lot of effort. Powder in a bottle or a capsule may be a suitable option, especially when looking for speed to the clinic. However, for poorly soluble molecules and late phase clinical testing, formulation development and more sophisticated dosage forms are often required to ensure scalability, targeted delivery, patient compliance or product differentiation. Every project is unique and requires experience to know which path to take, this is where AustinPx comes in. We partner with you to gather and interpret the data needed to make confident decisions at each stage of your molecule’s development.
AustinPx’s dose form development capabilities include:
- Tablets and Capsules
- Bioavailability Enhancement Technologies
- Extended and Targeted Release
- Patient Compliance Strategies (Reduction in Pill Burden)
- Process Development and Optimization
- Scale Up and Validation